US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Tevogen Bio Holdings Inc (TVGN)
Tevogen Bio Holdings Inc (TVGN) ニュース

TVGN

Tevogen Bio (TVGN)

Tevogen Bio Holdings Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TVGN

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/19	04 : 17	GlobeNewswire Inc.	Tevogen.AI Head Discusses Company’s Bold Strategy to Shape the Future of T Cell Therapies at Longwood Spring MIT Conference	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/06/13	04 : 45	GlobeNewswire Inc.	Tevogen Bio Set to Join Russell 3000® Index	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/06/12	04 : 30	GlobeNewswire Inc.	Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/06/08	04 : 32	GlobeNewswire Inc.	CORRECTION – Tevogen Bio Expresses Gratitude to Patients, First Responders, Elected Officials, and Members of the United States Congress for Attending Its Inaugural Post-Public Listing Social Engagement Event	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/06/07	07 : 14	GlobeNewswire Inc.	Tevogen Bio Expresses Gratitude to Patients, First Responders, Elected Officials, and Members of the United States Congress for Attending Its Inaugural Post-Listing Social Engagement Event	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/06/07	04 : 52	GlobeNewswire Inc.	Tevogen Bio Confirms Ongoing Efficacy of TVGN 489, Its Investigational Allogeneic Off-the-Shelf Immunotherapy, Against Dominant FLiRT Strains of SARS-CoV-2	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/05/29	21 : 00	GlobeNewswire Inc.	Tevogen Bio Reports First Quarter 2024 Financial Results	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/05/17	03 : 00	GlobeNewswire Inc.	Tevogen Bio Appoints Former Police Chief & FBI National Academy Graduate, William Keane, as Vice President of Strategic Initiatives	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/05/11	06 : 40	GlobeNewswire Inc.	Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational Objectives	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/05/01	21 : 05	GlobeNewswire Inc.	Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming Operational Objectives	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/04/26	22 : 23	GlobeNewswire Inc.	Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/04/11	21 : 05	GlobeNewswire Inc.	Tevogen Bio’s Chief Scientific Officer Speaks on the Harnessing of Cytotoxic T Lymphocytes (CTLs) to Target Cancers	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/04/03	21 : 05	GlobeNewswire Inc.	Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/03/28	21 : 05	GlobeNewswire Inc.	Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/03/20	20 : 00	Business Wire	Tevogen Bio Reports Its Investigational SARS-CoV-2 Specific T Cell Therapy, TVGN-489, Retains Activity Against the Dominant JN.1 Variant	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/03/05	22 : 00	Business Wire	Tevogen Bio Holdings Congratulates its Board Member and Esteemed Global Safety Management Expert, Victor Sordillo, on His appointment as Managing Director of Risk Advisory Services at Verita	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/03/05	06 : 24	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/02/28	06 : 39	Business Wire	Mittul Mehta, Head of Tevogen's Artificial Intelligence Initiative Tevogen.ai, Emphasizes Importance of Proactive Talent Development for Biopharmaceutical Sector to Allow Rapid Adoption of AI	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/02/23	10 : 13	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/02/23	10 : 09	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/02/22	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/02/21	21 : 00	Business Wire	Cell Therapy Company Tevogen Bio Holdings Inc. Prepares to Launch Crucial Genetic Predisposition Study in Preparation to Investigate the Potential of TVGN 489 to Address Critical Unmet Need for Long COVID Treatment	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/02/20	22 : 57	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/02/17	14 : 17	Business Wire	Cell Therapy Company Tevogen Bio Holdings Inc. (Nasdaq: TVGN) Rings Opening Bell at Nasdaq Exchange on February 15th, 2024, Begins Public Trading on the Open Market	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/02/17	07 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/02/17	07 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/02/17	07 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/02/17	07 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/02/17	07 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TVGN	Tevogen Bio Holdings Inc
2024/02/17	07 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TVGN	Tevogen Bio Holdings Inc

Showing the most relevant articles for your search:NASDAQ:TVGN

Deutsche Telekom (QX)

Invesco QQQ Trust Series 1

Verizon Communications

Health Care Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約